Publication: 4782

Publication: 4782

Identifying Premenopausal Patients with Early-Stage Hormone Receptor–Positive Breast Cancer at Minimal Risk of Distant Recurrence by Breast Cancer Index

DOI

Google Scholar

Citation:: JAMA Netw Open vol 8 (11)

Year:: 2025
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: No
SDC:: Yes
Book Volume:

Parents:: 4721
Children:: None

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:: Pfizer, Biotheranostics, Inc., Ipsen, DebioPharm, TerSera, AstraZeneca
Grants:: U10CA180821; SGK grant - KG080081; NHMRC grant numbers 351161, 510788, 1105058; SWOG - U10CA180888, UG1CA233160, UG1CA233329; ECOG-ACRIN - U10CACA180820, U10CA180794; NRG Oncology - U10CA180868, U10CA180822, UG1CA189867; CCTG - U10CA180863, 707213

Corr. Author:
Authors:: Ruth M. O'Regan Yue Ren Yi Zhang Gini F. Fleming Prudence A. Francis Olivia Pagani Barbara A. Walley Roswitha Kammler Patrizia Dell'Orto Giuseppe Viale Sherene Loi Marco Colleoni Kai Treuner Meredith M. Regan

Networks:: LAPS-IL057, NY167, OH070

Study: IBCSG-24-02 (SOFT-TEXT)
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: